NeoStem Awarded Grant to Test Stem Cells for Wound Healing

NeoStem received a $700,000 contract from the U.S. Army Medical Research grant to study the use of Primcel, a topically applied stem cell product designed to aid wound healing. Primcel uses adult stem cells derived from a person’s own bone marrow (mesenchymal stem cells) with the goal of speeding recovery and avoiding amputation in non-healing, chronic wounds. More details... Stock Symbol: (NYSE Amex: NBS)